IP Verse

Acuitas Therapeutics Inc. V. Alnylam Pharmaceuticals, Inc. - 1:24-cv-00816

Acuitas Therapeutics Inc. V. Alnylam Pharmaceuticals, Inc. (Case No. 1:24-cv-00816), filed on Jul 12, 2024 in the District Court, D. Delaware involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
1:24-cv-00816
Filing Date
Jul 12, 2024
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. Delaware
Nature of Suit
Patent

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Xinyao Du -
Alnylam Pharmaceuticals, Inc. -
Acuitas Therapeutics Inc. -
Steven M Ansell -
Michael J. Hope -

Patents Involved

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Dec 13, 2024REPLY to Response to Motion re 21 MOTION to Schedule a Rule 16 Conference and Supporting Memorandum filed by Acuitas Therapeutics Inc., Michael J. Hope, Steven M Ansell, Xinyao Du. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18)(Sharp, Melanie) (Entered: 12/13/2024)Attachment
Oct 3, 2024DECLARATION re 17 Answering Brief in Opposition, by Acuitas Therapeutics Inc., Steven M Ansell, Xinyao Du, Michael J. Hope. (Attachments: # 1 Exhibit Ex. 1 2024.10.01 Email from M. Kim to A. Penfield, # 2 Exhibit Ex.2 2024.10.02 Email from C. Wu to S. Columbia, W. Gaede, M. Kim, D. Tobin, and E. Townsend, # 3 Exhibit Ex.3 2024.10.02 Email from C. Wu to S. Burg, # 4 Exhibit Ex.4 2024.10.02 Email from C. Wu to M. Fodeman)(Sharp, Melanie) (Entered: 10/03/2024)Attachment
Dec 13, 2024REPLY to Response to Motion re 21 MOTION to Schedule a Rule 16 Conference and Supporting Memorandum filed by Acuitas Therapeutics Inc., Michael J. Hope, Steven M Ansell, Xinyao Du. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18)(Sharp, Melanie) (Entered: 12/13/2024)Attachment
Dec 13, 2024REPLY to Response to Motion re 21 MOTION to Schedule a Rule 16 Conference and Supporting Memorandum filed by Acuitas Therapeutics Inc., Michael J. Hope, Steven M Ansell, Xinyao Du. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18)(Sharp, Melanie) (Entered: 12/13/2024)Attachment
Dec 13, 2024REPLY to Response to Motion re 21 MOTION to Schedule a Rule 16 Conference and Supporting Memorandum filed by Acuitas Therapeutics Inc., Michael J. Hope, Steven M Ansell, Xinyao Du. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18)(Sharp, Melanie) (Entered: 12/13/2024)Attachment
Dec 13, 2024REPLY to Response to Motion re 21 MOTION to Schedule a Rule 16 Conference and Supporting Memorandum filed by Acuitas Therapeutics Inc., Michael J. Hope, Steven M Ansell, Xinyao Du. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18)(Sharp, Melanie) (Entered: 12/13/2024)Attachment
Dec 13, 2024REPLY to Response to Motion re 21 MOTION to Schedule a Rule 16 Conference and Supporting Memorandum filed by Acuitas Therapeutics Inc., Michael J. Hope, Steven M Ansell, Xinyao Du. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18)(Sharp, Melanie) (Entered: 12/13/2024)Attachment
Dec 13, 2024REPLY to Response to Motion re 21 MOTION to Schedule a Rule 16 Conference and Supporting Memorandum filed by Acuitas Therapeutics Inc., Michael J. Hope, Steven M Ansell, Xinyao Du. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18)(Sharp, Melanie) (Entered: 12/13/2024)Attachment
Dec 13, 2024REPLY to Response to Motion re 21 MOTION to Schedule a Rule 16 Conference and Supporting Memorandum filed by Acuitas Therapeutics Inc., Michael J. Hope, Steven M Ansell, Xinyao Du. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18)(Sharp, Melanie) (Entered: 12/13/2024)Attachment
Dec 13, 2024REPLY to Response to Motion re 21 MOTION to Schedule a Rule 16 Conference and Supporting Memorandum filed by Acuitas Therapeutics Inc., Michael J. Hope, Steven M Ansell, Xinyao Du. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18)(Sharp, Melanie) (Entered: 12/13/2024)Attachment
Dec 13, 2024REPLY to Response to Motion re 21 MOTION to Schedule a Rule 16 Conference and Supporting Memorandum filed by Acuitas Therapeutics Inc., Michael J. Hope, Steven M Ansell, Xinyao Du. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18)(Sharp, Melanie) (Entered: 12/13/2024)Attachment
Dec 13, 2024REPLY to Response to Motion re 21 MOTION to Schedule a Rule 16 Conference and Supporting Memorandum filed by Acuitas Therapeutics Inc., Michael J. Hope, Steven M Ansell, Xinyao Du. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18)(Sharp, Melanie) (Entered: 12/13/2024)Attachment
Dec 13, 2024REPLY to Response to Motion re 21 MOTION to Schedule a Rule 16 Conference and Supporting Memorandum filed by Acuitas Therapeutics Inc., Michael J. Hope, Steven M Ansell, Xinyao Du. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18)(Sharp, Melanie) (Entered: 12/13/2024)Attachment
Dec 13, 2024REPLY to Response to Motion re 21 MOTION to Schedule a Rule 16 Conference and Supporting Memorandum filed by Acuitas Therapeutics Inc., Michael J. Hope, Steven M Ansell, Xinyao Du. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18)(Sharp, Melanie) (Entered: 12/13/2024)Attachment
Dec 13, 2024REPLY to Response to Motion re 21 MOTION to Schedule a Rule 16 Conference and Supporting Memorandum filed by Acuitas Therapeutics Inc., Michael J. Hope, Steven M Ansell, Xinyao Du. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18)(Sharp, Melanie) (Entered: 12/13/2024)Attachment
Dec 13, 2024REPLY to Response to Motion re 21 MOTION to Schedule a Rule 16 Conference and Supporting Memorandum filed by Acuitas Therapeutics Inc., Michael J. Hope, Steven M Ansell, Xinyao Du. (Attachments: # 1 Certificate of Compliance, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18)(Sharp, Melanie) (Entered: 12/13/2024)Attachment
Jun 3, 2025NOTICE of Withdrawal of Appearance of Stephanie N. Vangellow by Acuitas Therapeutics Inc., Steven M Ansell, Xinyao Du, Michael J. Hope (Higgins, James) (Entered: 06/03/2025)PACER Document
Jul 1, 2025MEMORANDUM OPINION. Signed by Judge Colm F. Connolly on 7/1/2025. (mws) (Entered: 07/01/2025)PACER Document
Jul 1, 2025ORDER granting in part and denying in part 12 MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter. The Complaint (D.I. 1 ) is dismissed without prejudice. Signed by Judge Colm F. Connolly on 7/1/2025. (mws) (Entered: 07/01/2025)PACER Document
Aug 4, 2025NOTICE of Change of Law Firm Name by Alnylam Pharmaceuticals, Inc. (Townsend, Ethan) (Entered: 08/04/2025)PACER Document